FDA Clears Genentech's Tarceva for Lung Cancer
603826
Biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. on Thursday said U.S. regulators have approved their drug Tarceva as a treatment for the most common form of lung cancer.
534244
TUESDAY, March 13 (HealthDay News) -- GlaxoSmithKline&#39;s Tykerb (lapatinib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer when other cancer drugs haven&#39;t succeeded, the agency said Tuesday.
711508
MADISON, NJ - Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration (news - web sites) granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
298048
Eli Lilly and Co.&#39;s Alimta lung cancer medicine was as effective as Sanofi-Aventis SA&#39;s Taxotere treatment while causing fewer serious side effects in patients with advanced lung tumors, according to a study.
189115
LOS ANGELES/NEW YORK  - The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc's   drug Vectibix for the treatment of advanced colon cancer.
691847
Biotechnology stocks moved lower Friday as Genentech Inc. and OSI Pharmaceuticals lost value despite an earlier-than-expected approval of their lung cancer drug Tarceva.
738445
The Food and Drug Administration has given a Seattle company permission to resume its human tests of an experimental, gene-based arthritis treatment whose safety came into question this summer after a 36-year-old study participant died.
524945
The US Food and Drug Administration has granted fast-trackapproval to Tarceva (erlotinib) to treat advanced non-small cell lungcancer that has failed to respond to other therapy.
188330
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney ...
211121
Genentech Inc colon and lung cancer drug Avastin, along with standard chemotherapy, increases survival rates of patients with a very deadly type of brain tumor, U.S. researchers said on Thursday.
394537
A breakthrough cancer drug made by a Long Island company won federal approval late Thursday in a major victory for cancer patients and the region&#39;s budding biotech industry.
44693
Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc. -The Washington Post
185930
U.S. regulators cleared a new genetic test on Monday that helps predict tumor recurrence and long-term survival in breast cancer patients with higher risk of the cancer returning.
367403
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
438480
Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is &quot;good news&quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.